Literature DB >> 7725368

Aminopyrine metabolism in man: the acetylation of aminoantipyrine cosegregates with acetylation of caffeine.

J A Agúndez1, J A Carrillo, C Martínez, J Benítez.   

Abstract

Aminopyrine and caffeine metabolism was evaluated in vivo in 21 healthy volunteers in order to elucidate whether the acetylation capacity of the two substances correlates. The ratio of the aminopyrine metabolites 4-acetylaminoantipyrine (AAA)/4-aminoantipyrine (AA) was compared with the ratios of caffeine metabolites AAMU/1-X and AAMU/(AAMU + 1-X + 1-U). All the subjects phenotyped as slow acetylators with caffeine displayed AAA/AA ratios lower than 3.4, whereas the extensive acetylators had ratios higher than 3.8. Therefore, the acetylator phenotype determined with caffeine cosegregated with the capacity to acetylate the aminopyrine metabolite AA. The N-demethylation of aminopyrine and caffeine correlated strongly in the subjects studied (p < 0.001). A highly significant correlation (r = 0.92; p < 0.001) was also observed between caffeine N(1)- and N(7)-demethylation activities. In addition, most N-demethylation steps of both drugs significantly correlated, suggesting partial contributions by identical or closely related enzymes in their metabolism.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7725368

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN: 0163-4356            Impact factor:   3.681


  3 in total

1.  NMR-derived models of amidopyrine and its metabolites in complexes with rabbit cytochrome P450 2B4 reveal a structural mechanism of sequential N-dealkylation.

Authors:  Arthur G Roberts; Sara E A Sjögren; Nadezda Fomina; Kathy T Vu; Adah Almutairi; James R Halpert
Journal:  Biochemistry       Date:  2011-03-04       Impact factor: 3.162

2.  Cytochrome P450 1A2 is the most important enzyme for hepatic metabolism of the metamizole metabolite 4-methylaminoantipyrine.

Authors:  Fabio Bachmann; Henriette E Meyer Zu Schwabedissen; Urs Duthaler; Stephan Krähenbühl
Journal:  Br J Clin Pharmacol       Date:  2021-11-07       Impact factor: 3.716

3.  Validated HPLC determination of 4-dimethylaminoantipyrine in different suppository bases.

Authors:  E Kalmár; B Kormányos; G Szakonyi; G Dombi
Journal:  Indian J Pharm Sci       Date:  2014-01       Impact factor: 0.975

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.